Benign prostatic hyperplasia laboratory findings

Benign prostatic hyperplasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Benign Prostatic Hyperplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Benign prostatic hyperplasia laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Benign prostatic hyperplasia laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Benign prostatic hyperplasia laboratory findings
CDC on Benign prostatic hyperplasia laboratory findings
Benign prostatic hyperplasia laboratory findings in the news
Blogs on Benign prostatic hyperplasia laboratory findings
Directions to Hospitals Treating Benign prostatic hyperplasia
Risk calculators and risk factors for Benign prostatic hyperplasia laboratory findings

Steven C. Campbell, M.D., Ph.D.

Laboratory Findings

Often, blood tests are performed to rule out prostatic malignancy: elevated prostate specific antigen (PSA) levels needs further investigations such as reinterpretation of PSA results, in terms of PSA density and PSA free percentage, rectal examination and transrectal ultrasonography. These combined measures can provide early cancer detection.